Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company... Show more
KSPHF's Aroon Indicator triggered a bullish signal on July 07, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 103 similar instances where the Aroon Indicator showed a similar pattern. In of the 103 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Moving Average Convergence Divergence Histogram (MACD) for KSPHF turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.598) is normal, around the industry mean (62.701). P/E Ratio (9.183) is within average values for comparable stocks, (88.783). KSPHF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.031) settles around the average of (0.122) among similar stocks. P/S Ratio (1.753) is also within normal values, averaging (18.372).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KSPHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRGMX | 22.01 | 0.27 | +1.24% |
Nuveen Quant Mid Cap Growth Retire | |||
STRLX | 60.79 | 0.29 | +0.48% |
Sterling Capital MdCp Relatv Val A | |||
LCCAX | 38.59 | 0.15 | +0.39% |
Columbia Contrarian Core A | |||
ECOIX | 10.71 | 0.02 | +0.19% |
Ecofin Global Renewables Infras Ins | |||
SIDRX | 12.59 | -0.01 | -0.08% |
Hartford Schroders Intl Multi-Cp Val SDR |
A.I.dvisor tells us that KSPHF and MGWFF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KSPHF and MGWFF's prices will move in lockstep.
Ticker / NAME | Correlation To KSPHF | 1D Price Change % | ||
---|---|---|---|---|
KSPHF | 100% | N/A | ||
MGWFF - KSPHF | 7% Poorly correlated | N/A | ||
LVRLF - KSPHF | 5% Poorly correlated | +8.38% | ||
MILFF - KSPHF | 4% Poorly correlated | N/A | ||
HSTI - KSPHF | 1% Poorly correlated | N/A | ||
HTSUF - KSPHF | 0% Poorly correlated | N/A | ||
More |